The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer

Familial Cancer

Volumn 5, Issue 4, 2006, Pages 353-358

  Halvarsson, Britta ^a,c   Lindblom, Annika ^b   Rambech, Eva ^a   Lagerstedt, Kristina ^b   Nilbert, Mef ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HELSINGBORG HOSPITAL   (Sweden)

Author keywords

Hereditary nonpolyposis colorectal cancer; HNPCC; Immunostaining; PMS2

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN ANTIBODY; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN MUTL;

ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; NUCLEAR PROTEINS;

EID: 33845523843     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-006-0005-9     Document Type: Article

References (34)

1. Watson P, Lynch HT (2001) Cancer risk in mismatch repair gene mutation carriers. Fam Cancer 1:57-60
2. Hampel H, Stephens JA, Pukkala E, et al. (2005) Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129:415-421
3. Leach FS, Nicolaides NC, Papadopoulos N, et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225
4. Bronner CF, Baker SM, Morison PT, et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368:258-261
5. Papadopoulos N, Nicolaides NC, Wei YF, et al. (1994) Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629
6. Miyaki M, Konishi M, Tanaka K, et al. (1997) Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17:271-272
7. Peltomäki P, Vasen HF (2003) Mutations associated with HNPCC predisposition - update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20:269-276
8. Hamilton SR, Liu B, Parsons RE, et al. (1995) The molecular basis of Turcot's syndrome. N Engl J Med 332:839-847
9. Worthely DL, Walsh MD, Barker M, et al. (2005) Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer. Gastroenterology 128:1431-1436
10. Gryfe R, Gallinger S (2005) Germline PMS2 mutations: one hit or two? Gastroenterology 128:1506-1515
11. Hendriks YM, Jagmohan-Changur S, van der Klift HM, et al. (2006) Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal cancer. Gastroenterology 130:312-322
12. Boland CR, Thibodeau SN, Hamilton SR, et al. (1998) A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257
13. Moslein G, Tester DJ, Lindor NM, et al. (1996) Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet 5:1245-1252
14. Lindor NM, Burgart LJ, Leontovich O, et al. (2002) Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 20:1043-1048
15. Ruszkiewicz A, Bennett G, Moore J, et al. (2002) Correlation between mismatch repair gene immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 34:541-546
16. Rigau V, Sebbagh M, Olschwang S, et al. (2003) Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 immunostaining. Arch Pathol Lab Med 127:694-700
17. Halvarsson B, Lindblom A, Rambech E, et al. (2004) Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer. Virchows Arch 444:135-141
18. Shia J, Ellis NA, Klimstra DS (2004) The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch 445:431-441
19. Kolodner RD, Marsischky GT (1999) Eukaryotic DNA mismatch repair. Curr Opin Dev 9:89-96
20. Umar A, Boland RC, Terdiman JP, et al. (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268
21. Vasen HF, Watson P, Mecklin J-P, et al. (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116:1453-1456
22. Clendenning M, Hampel H, LaJeunesse J, et al. Long-range PCR facilitates the identification of PMS2 specific mutations. Hum Mutat, 2006; 27:490-495
23. Aaltonen LA, Salovara R, Kristo P, et al. (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338:1481-1487
24. Hampel H, Frankel WL, Martin E, et al. (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:1851-1860
25. Järvinen HJ, Aarnio M, Mustonen H, et al. (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834
26. Liljegren A, Lindgren G, Brandberg Y, et al. (2004) Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspects of surveillance by means of regular colonoscopies. J Clin Oncol 22:1736-1742
27. Gritz ER, Peterson SK, Vernon SW, et al. (2005) Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 23:1902-1910
28. Vasen HF, van Ballegooijen M, Buskens E, et al. (1998) A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 82:1632-1637
29. Gill S, Lindor NM, Burgart LJ, et al. (2005) Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res 11:6466-6471
30. de Jong A, van Puijenbrock M, Hendriks Y, et al. (2004) Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10:972-980
31. Engel C, Forberg J, Holinski-Feder F, et al. (2006) Novel strategy for optimal sequential application of clinical criteria, immunhistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. Int J Cancer 118:115-122
32. Muller W, Burgart LJ, Krause-Paulus R, et al. (2001) The reliability of immunohistochemistry as a pre-screening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) - results of an international collaborative study. Fam Cancer 1:87-93
33. Truninger K, Menigatti M, Luz J, et al. (2005) Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 128:1160-1171
34. Southey MS, Mark A, Jenkins LM, et al. (2005) Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 20:6524-6532